Does ENZALUTAMIDE Cause Investigation? 31 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 31 reports of Investigation have been filed in association with ENZALUTAMIDE (Xtandi). This represents 0.1% of all adverse event reports for ENZALUTAMIDE.
31
Reports of Investigation with ENZALUTAMIDE
0.1%
of all ENZALUTAMIDE reports
8
Deaths
31
Hospitalizations
How Dangerous Is Investigation From ENZALUTAMIDE?
Of the 31 reports, 8 (25.8%) resulted in death, 31 (100.0%) required hospitalization.
Is Investigation Listed in the Official Label?
Yes, Investigation is listed as a known adverse reaction in the official FDA drug label for ENZALUTAMIDE.
What Other Side Effects Does ENZALUTAMIDE Cause?
Fatigue (8,891)
Death (6,680)
Malignant neoplasm progression (4,696)
Prostatic specific antigen increased (3,731)
Asthenia (3,589)
Drug ineffective (3,468)
Hot flush (3,144)
Decreased appetite (3,069)
Nausea (2,898)
Dizziness (2,776)
What Other Drugs Cause Investigation?
ARANESP (403)
NEULASTA (371)
XGEVA (115)
FLUTICASONE\SALMETEROL (96)
DARBEPOETIN ALFA (86)
ADVAIR (77)
DENOSUMAB (65)
ADVAIR HFA (51)
ALBUTEROL (51)
VENTOLIN (47)
Which ENZALUTAMIDE Alternatives Have Lower Investigation Risk?
ENZALUTAMIDE vs EPCORITAMAB
ENZALUTAMIDE vs EPCORITAMAB-BYSP
ENZALUTAMIDE vs EPERISONE
ENZALUTAMIDE vs EPHEDRINE
ENZALUTAMIDE vs EPINASTINE